Metraipolis › archive › dc_cdbec595e65b

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose… — Europe PMC PMID:41476792

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41476792
DOI: 10.3389/fphar.2025.1725782
License (as archived): solo-consultazione
Archived: 2026-11-07T14:39:51.629Z
SHA-256 of the archived text: 0ce6c1faee5498d03b6fec00ecf7274f8bcafc37befe153f491b6ed7e603d577
Stable URL of this page: https://metraipolis.com/documento/dc_cdbec595e65b

How to cite

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose… — Europe PMC PMID:41476792 — Europe PMC (en), https://europepmc.org/article/MED/41476792 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdbec595e65b (Metraipolis archive dc_cdbec595e65b, sha256 0ce6c1faee5498d03b6fec00ecf7274f8bcafc37befe153f491b6ed7e603d577)

BibTeX

@misc{dccdbec595e65b,
  title = {Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose… — Europe PMC PMID:41476792},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476792},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdbec595e65b; sha256 0ce6c1faee5498d03b6fec00ecf7274f8bcafc37befe153f491b6ed7e603d577},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476792. Agents can read the archived copy with the MCP tool read_document.